Articles

The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lymphoma: results of a randomized UK National Cancer Research Institute trial

Derriford Hospital, Plymouth, UK
Cancer Reasearch UK and UCL Cancer Trials Centre, London, UK
University of Southampton, Southampton, UK
Musgrove Park Hospital, Taunton, UK
Addenbrookes Hospital, Cambridge, UK
Cancer Reasearch UK and UCL Cancer Trials Centre, London, UK
St. James’s University Hospital, Leeds, UK
HMDS, Leeds General Infirmary, UK
Musgrove Park Hospital, Taunton, UK
Cancer Reasearch UK and UCL Cancer Trials Centre, London, UK
Royal Cornwall Hospital, Truro, UK
Kent and Canterbury Hospital, Canterbury, UK
The Peter MacCallum Cancer Centre, Melbourne, Australia
Cancer Reasearch UK and UCL Cancer Trials Centre, London, UK
Maria Sklodowska-Curie Institute and Oncology Centre, Gilwice, Poland
UCL Cancer Institute, London, UK
Vol. 101 No. 2 (2016): February, 2016 https://doi.org/10.3324/haematol.2015.128710